Related Experiment Videos

Management of severe reflux in the patient with cyclophosphamide cystitis

The Journal of Urology
|October 1, 1983
PubMed

Insights

Cyclophosphamide-induced cystitis with severe vesicoureteral reflux can harm kidneys. Ileocecocystoplasty offers a successful management strategy, preventing further renal deterioration in affected patients.

Area of Science:

  • Urology
  • Pediatric Surgery
  • Nephrology

Background:

  • Cyclophosphamide treatment can cause hemorrhagic cystitis, leading to vesicoureteral reflux and potential renal damage.
  • High-grade vesicoureteral reflux in this context poses a risk of rapid upper tract deterioration.
  • Traditional surgical interventions like ureteral reimplantation are often contraindicated, and urinary diversion carries long-term risks, especially in pediatric cases.

Observation:

  • A pediatric patient presented with cyclophosphamide-induced cystitis and significant vesicoureteral reflux.
  • The patient exhibited signs of upper tract deterioration due to the reflux.
  • Conventional treatments were deemed unsuitable for this complex case.

Findings:

  • Successful management of cyclophosphamide cystitis with high-grade vesicoureteral reflux and renal deterioration was achieved using ileocecocystoplasty.
  • This surgical approach effectively addressed the reflux and protected renal function.
  • The ileocecocystoplasty procedure demonstrated a favorable outcome in this challenging clinical scenario.

Implications:

  • Ileocecocystoplasty should be considered as an early and effective management option for pediatric patients with cyclophosphamide cystitis and severe vesicoureteral reflux.
  • This technique may prevent long-term renal complications associated with this condition.
  • The findings support the utility of ileocecocystoplasty in preserving renal function in complex urological cases.

Related Concept Videos